top of page

Ketamine
Common Names: Special K

Type:

It has a role as an intravenous anaesthetic, a NMDA receptor antagonist, an analgesic, a neurotoxin, an environmental contaminant and a xenobiotic. Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic effects. It was FDA approved in 1970, and from there, it has been used as an anesthetic for children or patients undergoing minor surgeries but mainly for veterinary purposes.

Ketamine.png
Formula: C13H16ClNO
slot 1
slot 2
slot 3

Mental Effects

Potential Risks

Legality & Therapeutic Uses

  • Dissociation, out-of-body experiences, euphoria, numbness, analgesia

  • Type: Dissociative anesthetic with psychedelic effects

  • Confusion, nausea, bladder/kidney issues with heavy use, addictive potential

  • Schedule III in U.S.; legal medical uses

  • Medical Use: Anesthetic; FDA-approved for treatment-resistant depression (as esketamine)

slot 4

Interesting Facts

  • hmmm

slot 5

Harm Reduction Tips

  • hmm

slot 6

Physical Effects

  • Ketamine is a General Anesthetic. The physiologic effect of ketamine is by means of General Anesthesia.

slot 7

Physical Properties

State: 

slot 8

Forms

  • hmm

slot 9

Onset and Duration

Snorted: 5–15 min onset, 45–90 min duration; IV: rapid onset, shorter duration

Mechanisms of Action
Pharmacology and Biochemistry
ketamine mech.jpg

Watson, Jack & Halpin, Laura & Barroso, Violeta & Dahdouh, George & Bursalyan, Jacqueline & Mohta, Saahil & Flores, Michelle & Gonzalez, Natalie & Gordineer, John & Medina, Germain & Oseguera, Crystal & Serrano, Jailene. (2025). A Review of the Food and Drug Administration Pipeline and Proposed California Legislation on Medicinal Psychedelics. The Permanente Journal. 29. 89-101. 10.7812/TPP/24.171. ​

References
Join The Silicon Valley Psychedelic Society

Sign up to be apart of the community, establish membership and receive our newsletter to stay informed about upcoming events, meetup's, and community initiatives.

  • Instagram

DISCLAIMER: This website and its representatives do not provide medical advice. The information contained on this website is for educational purposes only, has not been evaluated by the FDA. The Silicon Valley Psychedelic Society does not endorse, encourage or promote the use of psychedelics, nor do we encourage or condone any illegal activity. You are solely responsible for understanding and complying with all laws that may be applicable to you. Read our full disclaimer. 

JOIN THE MOVEMENT

  • Instagram

 

© 2025 Silicon Valley Psychedelic Society

 

bottom of page